SK14812001A3 - Maduraftalazínové deriváty a ich použitie ako inhibítorov prozápalových cytokínov - Google Patents

Maduraftalazínové deriváty a ich použitie ako inhibítorov prozápalových cytokínov Download PDF

Info

Publication number
SK14812001A3
SK14812001A3 SK1481-2001A SK14812001A SK14812001A3 SK 14812001 A3 SK14812001 A3 SK 14812001A3 SK 14812001 A SK14812001 A SK 14812001A SK 14812001 A3 SK14812001 A3 SK 14812001A3
Authority
SK
Slovakia
Prior art keywords
alkyl
aryl
carbon atoms
mono
group
Prior art date
Application number
SK1481-2001A
Other languages
English (en)
Slovak (sk)
Inventor
Regina Draheim
Thomas Kronbach
Lothar Heinisch
Ernst Roemer
Norbert Hfgen
Hildegard Poppe
Peter J�Tten
Wolfgang Haas
Walter Werner
Udo Gr�Fe
Original Assignee
Arzneimittelwerk Dresden Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arzneimittelwerk Dresden Gmbh filed Critical Arzneimittelwerk Dresden Gmbh
Publication of SK14812001A3 publication Critical patent/SK14812001A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Otolaryngology (AREA)
  • Hematology (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK1481-2001A 1999-04-17 2000-04-11 Maduraftalazínové deriváty a ich použitie ako inhibítorov prozápalových cytokínov SK14812001A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19917505A DE19917505A1 (de) 1999-04-17 1999-04-17 Verwendung von Maduraphthalazin-Derivaten als Inhibitoren proinflammatorischer Cytokine
PCT/EP2000/003182 WO2000063181A1 (de) 1999-04-17 2000-04-11 Verwendung von maduraphthalazin-derivaten als inhibitoren proinflammatorischer cytokine

Publications (1)

Publication Number Publication Date
SK14812001A3 true SK14812001A3 (sk) 2002-05-09

Family

ID=7904992

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1481-2001A SK14812001A3 (sk) 1999-04-17 2000-04-11 Maduraftalazínové deriváty a ich použitie ako inhibítorov prozápalových cytokínov

Country Status (24)

Country Link
US (1) US6440968B1 (xx)
EP (1) EP1171425A1 (xx)
JP (1) JP2002542232A (xx)
KR (1) KR20010108515A (xx)
CN (1) CN1347408A (xx)
AU (1) AU4546100A (xx)
BG (1) BG106009A (xx)
BR (1) BR0009821A (xx)
CA (1) CA2305893A1 (xx)
CZ (1) CZ20013712A3 (xx)
DE (1) DE19917505A1 (xx)
EA (1) EA200101096A1 (xx)
EE (1) EE200100537A (xx)
HK (1) HK1039932A1 (xx)
HU (1) HUP0200783A3 (xx)
IL (1) IL145600A0 (xx)
IS (1) IS6093A (xx)
MX (1) MXPA01010050A (xx)
NO (1) NO20015033L (xx)
SK (1) SK14812001A3 (xx)
TR (1) TR200102984T2 (xx)
WO (1) WO2000063181A1 (xx)
YU (1) YU72601A (xx)
ZA (1) ZA200107886B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210535D0 (en) * 2002-05-08 2002-06-19 Novartis Ag Organic compounds
EP2095823A1 (en) * 2002-07-30 2009-09-02 Stem Cell Therapeutics Inc. GM-CSF for treating demyelination
US20070042978A1 (en) * 2002-12-19 2007-02-22 Jean-Philippe Girard Nf-hev compositions and methods of use
US20080096947A1 (en) * 2004-10-15 2008-04-24 Heidelberg Pharma Ag Parenteral Forms Of Administration Of Imexon And Method For The Production Thereof
ATE421956T1 (de) * 2006-09-19 2009-02-15 Leibniz Inst Naturstoff Forsch Antibiotikum maduraphthalazin-salze mit verzögerter wirkstofffreigabe des wirkstoffs und deren verwendung
RU2735203C2 (ru) 2016-07-11 2020-10-28 Филип Моррис Продактс С.А. Гидрофобная капсула
WO2020126035A1 (en) * 2018-12-21 2020-06-25 Fondazione Istituto Insubrico Di Ricerca Per La Vita Novel aza-hexaphene antibiotic compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE7706C (de) * Dr. G. H. E. BERING in Bromberg Verfahren zur Entbitterung von Lupinen mit Hülfe kohlensaurer Alkalien
DE19719522A1 (de) * 1996-08-17 1998-02-19 Gruenenthal Gmbh Neue polycyclische Phthalazinderivate, Verfahren zu Ihrer Herstellung und ihre Verwendung

Also Published As

Publication number Publication date
CN1347408A (zh) 2002-05-01
DE19917505A1 (de) 2000-10-19
US6440968B1 (en) 2002-08-27
IS6093A (is) 2001-09-28
YU72601A (sh) 2004-05-12
HUP0200783A3 (en) 2002-12-28
CZ20013712A3 (cs) 2002-03-13
NO20015033D0 (no) 2001-10-16
HK1039932A1 (zh) 2002-05-17
IL145600A0 (en) 2002-06-30
EA200101096A1 (ru) 2002-04-25
EE200100537A (et) 2002-12-16
CA2305893A1 (en) 2000-10-17
BR0009821A (pt) 2002-01-15
ZA200107886B (en) 2004-03-29
JP2002542232A (ja) 2002-12-10
WO2000063181A1 (de) 2000-10-26
EP1171425A1 (de) 2002-01-16
AU4546100A (en) 2000-11-02
BG106009A (en) 2002-06-28
NO20015033L (no) 2001-11-21
MXPA01010050A (es) 2002-04-24
HUP0200783A2 (hu) 2002-11-28
KR20010108515A (ko) 2001-12-07
TR200102984T2 (tr) 2002-03-21

Similar Documents

Publication Publication Date Title
EP1307457B1 (fr) Composes azabicycliques, leur preparation et leur utilisation comme medicaments , notamment comme anti-bacteriens
RU2277095C2 (ru) Замещенные бета-карболины
EP1475377B1 (de) Indolderivate und deren Verwendung als Inhibitoren der Phosphodiesterase 4.
JPH04230389A (ja) ラパマイシン誘導体
HUT62590A (en) Process for producing rapamycin amide esters
JPH10500661A (ja) ラパマイシン誘導体
EP0946541B1 (en) Quinolines and their therapeutic use
CZ296163B6 (cs) Karboxyamidy chinolinu jako inhibitory TNF a inhibitory PDE-IV
PL175347B1 (pl) Trójpierścieniowe heterocykliczne aminy aktywne farmaceutycznie
EP1330455B1 (de) Neue 7-azaindole, deren verwendung als inhibitoren der phosphodiesterase 4 und verfahren zu deren herstellung
MX2011004704A (es) Compuesto de carbamato o sal del mismo.
SK133997A3 (en) Derivatives of ascomycin, method for the preparation thereof and pharmaceutical composition containing the same
WO2004104000A1 (ja) トリサイクリック縮合環化合物およびその医薬用途
SK14812001A3 (sk) Maduraftalazínové deriváty a ich použitie ako inhibítorov prozápalových cytokínov
AU2004232483B2 (en) 7-azaindoles and use thereof as therapeutic agents
CN115197190A (zh) 一种新型植物黄酮衍生物及其制备方法和应用
CN115504909A (zh) 一种苯酰胍衍生物及其制备方法和应用
CN115073329A (zh) 一种新型益母草碱衍生物及其制备方法和应用
DE19618999A1 (de) Neue Benzothiazolinone
US6262070B1 (en) Heterocyclic compounds and their therapeutic use
JP7495758B2 (ja) マクロライド化合物及びその慢性呼吸器疾患の治療用途
WO2021233427A1 (zh) 并环化合物及其制备方法、药物组合物和应用
CN115260090A (zh) 一种新型苯并酮类衍生物及其制备方法和应用
DE10053275A1 (de) Neue 7-Azaindole, deren Verwendung als Inhibitoren der Phosphodiesterase 4 und Verfahren zu deren Herstellung
DE19618970A1 (de) Neue Thiazolopyridine